PODCAST: President Trump’s Early Trade Policy Moves – What it Means for Business — C&M’s First 100 Days Series
Client Alert | 1 min read | 02.03.17
As part of Crowell & Moring’s “First 100 Days” series, Paul Davies and Andrew Blasi of C&M International, Crowell & Moring’s international policy and regulatory affairs consulting affiliate, discuss the trade policy moves made so far by the Trump Administration, and what it means for businesses who are involved in trade issues. Paul is a director at C&M International and a former Australian trade negotiator. Andrew is an associate director at C&M International and a former staff member of the US-ASEAN Business Council and the U.S. House of Representatives.
Covered in this 16 minute podcast:
- President Trump’s early trade policy emphasis on limiting imports and eliminating the trade deficit.
- Implications of the U.S. withdrawal from TPP and the main takeaways for businesses.
- The president’s upcoming meeting with Prime Minister Abe of Japan and where things stand.
- Thoughts on NAFTA and what businesses might expect.
Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
